- The Infectious Diseases Society of America (IDSA) released its first-ever guidelines for the treatment of methicillin resistant Staphylococcus aureus (MRSA), which will help physicians determine the most appropriate care for infections due to the common bacterium.
- MRSA is the most common cause of skin infections that send people to the emergency room. Its invasive form kills about18,000 people a year.
- Treatment of MRSA varies widely. The guidelines will help physicians make good treatment decisions, which may mean not prescribing antibiotics for some of the less complicated forms of the infection.
Physicians now have help in their battle against methicillin resistant
Staphylococcus aureus (MRSA), a potentially deadly infection that initially was limited to hospitals and health care facilities but has become a growing problem in healthy children and adults. The Infectious Diseases Society of America (IDSA) has released its first guidelines for the treatment of increasingly common MRSA infections.
An antibiotic-resistant "superbug," MRSA is responsible for about 60 percent of skin infections seen in emergency rooms. The guidelines address treatment of these common infections, which are frequently mistaken for spider bites. They also address treatment of invasive MRSA, which is less common but far more serious, including pneumonia and infections of the blood, heart, bone, joints and central nervous system. Invasive MRSA kills about 18,000 people every year.
To be published in the Feb. 1 issue of
Clinical Infectious Diseases, the guidelines are intended to guide physicians in their use of antibiotics for treatment of this common infection. Current treatment varies widely.